ORTEXORTEX News
Tracking LRCX? Get live short interest, options flow, and signals on ORTEX.Sign up free →
LR
Earnings PreviewLRCX

LRCX Posts a Shallower Drop Than Peers, Short Interest Unchanged at 2%

By ORTEX News · Edited by , Editor, ORTEX News2 min readdata as of 22 Oct 2026, 04:01

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Lam Research lost another 9.1% over the past week to close at $260.81, a softer drop than the semiconductor equipment peer median of roughly 13.7%, as the sector rotation that began in early October continued to grind the group lower.

The borrow market carries no directional signal worth calling a story. Short interest has barely moved in either direction, sitting at 2% of the free float, up about 1.8% on the week but still near the low end of its September-to-October range. A month ago it was closer to 4%. Borrow costs are minimal at 0.40%, up 65% on the week in percentage terms but from an extremely low base; the absolute cost remains negligible. Availability is effectively unlimited, with over a billion shares available to borrow and no sign of tightening. Nothing in the lending market suggests new short-side conviction is driving the price lower.

Options positioning has actually eased compared to its recent norm. The put/call ratio has fallen to 1.09, roughly two standard deviations below its 20-day average of 1.13. That is near the one-year low for the ratio, meaning the options market is carrying less downside protection than at almost any point in the past year, despite the stock's 9.5% monthly decline.

Analyst direction has split heading into the print. Evercore ISI's Mark Lipacis trimmed his target to $315 from $355 on October 20, maintaining his Outperform rating but pulling back on valuation ahead of results. That cut contrasts with Morgan Stanley, which raised to $385 from $367 earlier this month, and B. Riley, which lifted to $390 from $350 in early October. The divide reflects the core debate: bulls point to management's raised calendar 2026 wafer fab equipment outlook above $140 billion, sustained memory and foundry demand, and a track record of six consecutive quarters beating estimates. Bears lean on LRCX's 2.4 beta, China policy exposure, and rising competition from Tokyo Electron, AMEC and Naura as reasons the premium is harder to justify at this point in the cycle.

Wikipedia traffic for LRCX reached a z-score of 4.2 against its own 90-day history as of October 13, a notable spike in retail attention ahead of the print. The dataset is not measured as a leading indicator of the company's financial results, so it describes interest, not outcome. Still, with the stock at $260.81 and the lowest current analyst target at $315, the print will test whether the company's reported figures close any of the gap that the sector de-rating opened.

Stocks in this article

See the live data behind this article on ORTEX.

Open LRCX on ORTEX →

How this article was generated

Generated
22 Oct 2026, 04:13
Data as of
22 Oct 2026, 04:01
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.